000 01450 a2200421 4500
005 20250513212441.0
264 0 _c20000621
008 200006s 0 0 eng d
022 _a0160-6689
024 7 _a10.4088/jcp.v61n0502
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCiapparelli, A
245 0 0 _aClozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study.
_h[electronic resource]
260 _bThe Journal of clinical psychiatry
_cMay 2000
300 _a329-34 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aBipolar Disorder
_xdrug therapy
650 0 4 _aClozapine
_xtherapeutic use
650 0 4 _aComorbidity
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aPsychotic Disorders
_xdrug therapy
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aSuicide
_xpsychology
650 0 4 _aTreatment Outcome
700 1 _aDell'Osso, L
700 1 _aPini, S
700 1 _aChiavacci, M C
700 1 _aFenzi, M
700 1 _aCassano, G B
773 0 _tThe Journal of clinical psychiatry
_gvol. 61
_gno. 5
_gp. 329-34
856 4 0 _uhttps://doi.org/10.4088/jcp.v61n0502
_zAvailable from publisher's website
999 _c10798569
_d10798569